The Maytansnoid conjugate clearly is a large tumor killer the no longer requires an Antibody Conjugate Drug (ACD) as a targeted linker. This is a game charger for large tumor treatment.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.